Nasdaq:trow articles
-
Hartline Investment Corp Sells 410 Shares of T. Rowe Price Group, Inc. (NASDAQ:TROW)
Hartline Investment Corp decreased its position in shares of T. Rowe Price Group, Inc. (NASDAQ:TROW – Free Report) by 3.1% during the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 13,025 shares of the asset manager’s stock after selling 410 shares during the quarter. Hartline […]
-
AtriCure (NASDAQ:ATRC) Raised to Outperform at Oppenheimer
Oppenheimer upgraded shares of AtriCure (NASDAQ:ATRC – Free Report) from a market perform rating to an outperform rating in a research report sent to investors on Tuesday morning, Marketbeat.com reports. They currently have $32.00 target price on the medical device company’s stock. Other research analysts have also recently issued reports about the stock. Stifel Nicolaus […]
-
Accolade (NASDAQ:ACCD) Releases Earnings Results
Accolade (NASDAQ:ACCD – Get Free Report) issued its quarterly earnings data on Thursday. The company reported ($0.10) EPS for the quarter, beating the consensus estimate of ($0.11) by $0.01, Briefing.com reports. The firm had revenue of $124.80 million during the quarter, compared to the consensus estimate of $123.91 million. Accolade had a negative net margin […]